Mar 16, 2022 / 05:35PM GMT
Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst
Good afternoon, everyone. My name is Luke Sergott. I cover life sciences tools and diagnostics at Barclays. It's my pleasure to introduce, this as not Ron, it's Mike Fedock. He's the Head of FP&A from -- and former CFO of the RDS business at IQVIA; and Nick Childs. Ron was sick today. So Mike's subbing in.
Michael Fedock - IQVIA Holdings Inc. - SVP of Financial Planning and Analysis
Yes. It was hard to express my dedication to IQVIA to agree upon to South Florida on short notice, but that's the sacrifices I make for Ron and Ari.
Questions and Answers:
Luke England Sergott - Barclays Bank PLC, Research Division - Research AnalystAll right. That's great. So I guess, as I've been doing with everybody else, let's just dive right into the macro here, go through -- let's start with the Ukraine-Russia invasion. Anything that you're seeing there from a demand perspective, any knock-on effects for trials, things like that?